Hanyang University Guri Hospital Excels in Asthma Treatment

Hanyang University Guri Hospital, under the direction of Seung-Hwan Lee, has demonstrated its exceptional capabilities in treating asthma, solidifying its position as a leading institution for respiratory diseases.

The hospital recently announced that it received an excellent score in the ‘2023 (10th) Asthma Appropriateness Evaluation’ conducted by the Health Insurance Review and Assessment Service. This evaluation aims to enhance the quality of medical services for asthma patients.

The assessment, which took place from January 2023 to December 2023, evaluated various medical treatment aspects, including pulmonary function test implementation rates, continuous visit percentages, and ICS prescription rates. Additional monitoring indicators included hospitalization rates due to asthma and other relevant factors.

Hanyang University Guri Hospital’s outstanding performance in the asthma adequacy evaluation solidifies its reputation as a premier institution for treating respiratory diseases, such as asthma, chronic obstructive pulmonary disease, and tuberculosis.

Director Seung-Hwan Lee attributed the hospital’s success to the dedication of its staff, stating, “Our excellent results are a direct result of our team’s tireless efforts to provide patient-centered care.” This commitment to delivering high-quality treatment has earned the hospital its esteemed position in the field of respiratory medicine.